Pseudophakic cystoid macular edema is swelling in the very center of the retina (the macula) that happens after cataract surgery. “Pseudophakic” means there is an artificial lens inside the eye after the natural lens has been removed. “Cystoid” means the swelling collects in tiny fluid-filled spaces that look like little cysts. “Macular edema” means the macula gets water-logged and thick. The macula is the small, special spot in the back of the eye that gives you sharp central vision for reading, recognizing faces, and seeing fine detail. When fluid leaks into the macula after surgery, the layers separate a little and tiny pockets of fluid form. The macula becomes thicker, and vision becomes blurry or wavy. This condition is also called Irvine–Gass syndrome. It is usually painless. It most often shows up a few weeks after cataract surgery, but it can also appear later. Most people improve with the right care, especially when it is found early.
Pseudophakic cystoid macular edema (PCME) is swelling in the center of the retina (the macula) that happens after cataract surgery. Doctors also call it Irvine–Gass syndrome. In PCME, tiny fluid-filled spaces (“cysts”) collect in the macula because surgery-triggered inflammation loosens the tight seals in retinal blood vessels. This swelling blurs the sharp, central vision you use for reading, faces, and fine detail. In many people the swelling is mild and temporary, and vision improves as the inflammation calms down. Some cases last longer and need treatment. PCME is still one of the most common causes of less-than-expected vision after otherwise successful cataract surgery. EyeWiki
How it happens
Cataract surgery is very successful and safe, but surgery still triggers a healing response. During and after surgery, the eye releases chemical messengers called prostaglandins and other inflammatory molecules. These chemicals make the small blood vessels in the retina more “leaky.” The normal barriers that keep fluid out of the retina become weaker. Fluid slowly seeps out of those vessels and collects in the macula in round spaces between the layers of retinal cells. If there is extra pulling on the macula from the gel inside the eye (the vitreous), the leakage can be worse. If there are other eye problems like diabetes, uveitis, or a surgical complication, the leak and the swelling can last longer. The thicker the macula, the more the sharp central vision drops.
Anyone who has cataract surgery can get PCME, but the chance is higher if the surgery is complicated, if there is diabetes or inflammation in the eye, or if there is traction from the vitreous. Having macular edema in the other eye before, having a malpositioned lens implant, having retained lens fragments, or restarting certain glaucoma drops too soon after surgery can also raise risk. Early treatment usually helps, and many cases settle with drops alone.
Types
1) By timing
Acute PCME: Starts within about 4–12 weeks after cataract surgery. Many cases get better over weeks to a few months with anti-inflammatory treatment.
Chronic PCME: Swelling lasts longer than about 3–4 months, or keeps coming back. Chronic cases may need more than drops, and doctors look carefully for hidden causes like traction or a malpositioned lens.
2) By severity on exam or OCT
Mild: Small increase in macular thickness with tiny cysts. Vision may be only slightly blurry.
Moderate: Obvious cysts with more thickness. Vision is clearly reduced and reading becomes hard.
Severe: Large cysts, big increase in thickness, or a small central detachment of the retina (foveal detachment). Vision is notably down.
3) By driver
Inflammation-predominant: Caused mainly by postoperative inflammatory chemicals.
Traction-associated: Worsened by pulling from the vitreous, an epiretinal membrane, or vitreomacular traction.
Complication-associated: Linked to problems like posterior capsule rupture, retained lens pieces, or a lens in the wrong position.
Systemic/medication-associated: Worsened by diabetes or certain medicines like prostaglandin-analog glaucoma drops used too early after surgery.
Recurrent or refractory PCME: Keeps returning when drops are tapered, or does not fully respond to standard care.
Causes
Normal postoperative inflammation that is stronger than usual
Surgery starts a healing response. Some eyes make more prostaglandins and other inflammatory signals. These chemicals open tiny gaps in retinal vessels, so fluid leaks into the macula and forms cysts.Posterior capsule rupture during surgery
If the thin back capsule that holds the lens tears, the surgery gets more complex. Extra manipulation raises inflammation, and vitreous may shift forward. Both factors increase macular leak and swelling.Vitreous prolapse or vitreous to the wound
If the eye’s inner gel strands move forward and get caught in the incision or behind the iris, they can tug on the macula and promote leakage. That traction keeps fluid from clearing.Retained lens fragments
Small pieces of the old lens left behind can keep the eye inflamed for weeks. Ongoing inflammation makes macular blood vessels leaky until the fragments are removed or the inflammation is controlled.Iris trauma or a floppy iris (IFIS) with lots of manipulation
Stretching, chafing, or prolonged handling of the iris raises postoperative inflammation. More inflammation means more prostaglandins and more macular leakage.Malpositioned intraocular lens (IOL)
A lens that rubs the iris or sits wrongly can cause chronic irritation. This irritation keeps the eye inflamed and sustains macular edema.Anterior chamber or sulcus lens that chafes (UGH syndrome risk)
A lens placed in front of the iris or in the sulcus when it is not designed for that position can rub the iris, causing Uveitis, Glaucoma, and Hyphema. The uveitis part feeds macular edema.Early Nd:YAG capsulotomy
Laser opening of a cloudy capsule is helpful but, if done early while inflammation is still active, it can briefly increase inflammatory signals and trigger or worsen macular edema.Diabetes mellitus, especially with diabetic retinopathy
Diabetes damages retinal vessels and weakens the blood-retinal barrier. After surgery, diabetic eyes leak more and clear fluid more slowly, so macular edema is more likely and may last longer.Pre-existing epiretinal membrane (ERM)
A thin, cellophane-like membrane on the macula can wrinkle the surface and pull gently on the retina. This traction encourages cyst formation and slows recovery.Vitreomacular traction (VMT) or incomplete posterior vitreous detachment
If the gel is still attached tightly to the macula, it can tug during healing. That mechanical pull worsens leak and makes edema persistent.Uveitis (past or present)
People with a history of eye inflammation already have a sensitive, “primed” immune environment. Surgery can reignite inflammation, and the macula becomes swollen more easily.Retinal vein occlusion history
Vein blockages make retinal vessels fragile and leaky. After cataract surgery, these eyes are more prone to macular edema or have a harder time clearing it.Prostaglandin-analog glaucoma drops restarted too soon
Drops like latanoprost lower pressure very well, but they are prostaglandin-like and can increase vascular leak. If started early post-op, they may provoke or prolong edema in some eyes.Complicated or prolonged surgery
Longer time in the eye, small pupils, dense cataracts, or extra tools mean more tissue handling and more postoperative inflammation, which supports cyst formation.Previous PCME in the fellow eye
If one eye had this problem, the other eye seems at higher risk. It may reflect a personal tendency to stronger inflammation or hidden traction.Aphakia (no lens implant)
Without a lens or capsule partition, inflammatory signals and vitreous movement can spread differently inside the eye, and the macula may swell more easily.Wound leak or postoperative hypotony
Very low eye pressure after surgery can change fluid dynamics and may indirectly worsen macular edema until the leak is sealed and the pressure normalizes.Postoperative infection or toxic inflammation (endophthalmitis or TASS)
True infection or a severe sterile reaction is rare but causes intense inflammation. That state strongly promotes macular leakage and cysts.Systemic drugs that can cause CME (for example, high-dose niacin)
A few medicines can cause or worsen macular edema on their own. If they are taken around the time of surgery, the risk of PCME can be higher, and the edema can linger.
Symptoms
Painless blurry central vision
Things in the middle of your sight look fuzzy. This is the most common symptom and usually starts weeks after surgery.Wavy or distorted lines (metamorphopsia)
Straight edges on doors, tiles, or lines on a page look bent or rippled because the macula is swollen and uneven.Reduced reading ability
Letters blur or merge, and you may lose your place. You might hold materials closer or farther without finding a “sweet spot.”Central gray or smudged spot
Some people notice a faint dark patch or a hazy area right where they look. It can make faces harder to recognize.Lower contrast sensitivity
Shades of gray blend together. Low-contrast print, dim menus, and gray-on-white text become difficult.Color dullness
Colors seem washed out. Reds or blues look less rich because the macula processes color, and swelling slows that function.Glare and halos
Bright lights feel harsher. Night driving can be uncomfortable because glare scatters on the swollen tissue.Needing more light to see
You find yourself turning on more lamps or using brighter settings to read or do close work.Difficulty with faces
Features lack crisp edges, so recognizing people across a room is harder.Trouble with fine detail
Small print, sewing, or phone icons are fuzzy even with a new glasses prescription.Vision that fluctuates during the day
Blurring may be better at one time and worse later, depending on fluid shifts and fatigue.Micropsia (things look slightly smaller)
Objects may seem minutely shrunken because the swollen macula changes the way images are sampled by photoreceptors.Eyestrain with near tasks
You work harder to keep print clear. The effort can cause fatigue even without pain.Mild light sensitivity
Inflammation and swelling can make bright light uncomfortable though true pain is unusual.Slow recovery after looking at bright light
After glare, vision takes longer to “snap back,” a sign that macular cells are stressed.
Diagnostic tests
A) Physical examination
1) Best-corrected visual acuity (distance and near)
You read letters on a chart with and without lenses. PCME usually lowers central sharpness. Measuring acuity establishes the baseline, shows how much vision dropped, and helps track recovery as swelling goes down.
2) Refraction (finding your exact lens power)
The doctor checks whether a change in glasses helps. With PCME, a new refraction rarely restores full clarity because the main problem is macular swelling, not lens focus. This helps separate optical blur from retinal blur.
3) Tonometry (eye pressure measurement)
Eye pressure is checked because very low or high pressure after surgery can affect healing and treatment choices. It also guides safe use of steroid drops, which can raise pressure in some people.
4) Slit-lamp examination of the front of the eye
A microscope examines the cornea, wound, iris, and lens implant. The doctor looks for inflammatory cells and flare (signs of irritation), a wound leak, a malpositioned lens, or hints of a lens fragment. These clues point to treatable drivers of edema.
5) Dilated fundus examination with macular biomicroscopy
With the pupil enlarged, the doctor uses special lenses to view the macula. In PCME, the foveal reflex is dull, and the macula can look thickened. The doctor also looks for epiretinal membrane or vitreous traction that may prolong edema.
B) Manual/bedside functional tests
6) Amsler grid
You look at a grid of straight lines. Wavy or missing lines suggest macular distortion or a small central scotoma. This simple tool documents metamorphopsia and helps monitor change at home.
7) Pinhole test
Looking through a tiny hole reduces blur from focusing errors. If vision stays poor through the pinhole, the problem is more likely in the retina, which supports the diagnosis of macular edema.
8) Contrast sensitivity testing (e.g., Pelli-Robson)
This measures how well you see faint, low-contrast letters. PCME often lowers contrast even when the standard eye chart looks only moderately reduced.
9) Color vision testing (simple plates or more detailed tests)
Macular disease can subtly reduce color discrimination. A quick color test can support the functional impact of swelling and gives another baseline to follow.
C) Laboratory and pathological tests
10) Blood glucose and HbA1c
These tests check sugar control in people with diabetes. Poor control increases the risk of PCME and slows recovery. Knowing the numbers helps coordinate care with the primary doctor to support the eye’s healing.
11) Aqueous or vitreous tap for culture/PCR (only if infection is suspected)
If signs point to infection after surgery (pain, severe redness, hypopyon), a tiny fluid sample is taken to look for germs. This is not routine for typical PCME but is essential when endophthalmitis is on the table because infection-driven inflammation can cause macular edema.
12) Complete blood count and inflammatory markers (CBC, ESR/CRP) when uveitis is in the differential
If there are features of deeper inflammation, basic blood tests help a broader uveitis work-up. While they do not diagnose PCME directly, they help reveal systemic inflammation that sustains macular swelling.
13) Renal and liver function tests before systemic medicines (when needed)
If systemic NSAIDs or certain carbonic anhydrase inhibitors are considered for stubborn cases, doctors may check kidney and liver function first. Safe dosing supports treatment while monitoring the edema.
D) Electrodiagnostic tests
14) Multifocal electroretinography (mfERG)
This test measures electrical signals from the macula. In PCME, signals from the central retina can be reduced, correlating with visual loss. mfERG helps separate macular dysfunction from optic nerve problems.
15) Visual evoked potential (VEP)
VEP records electrical responses from the brain to a visual stimulus. If VEP is relatively normal while vision is down, that points to a macular problem rather than an optic nerve disorder. It is not routine but can help in complex cases.
E) Imaging tests
16) Spectral-domain optical coherence tomography (SD-OCT)
OCT is the key test. It uses light waves to make cross-section images of the retina. In PCME it shows round “cystoid” spaces, increased thickness, and sometimes a small central detachment. OCT guides diagnosis, measures severity, and tracks response to treatment over time.
17) OCT angiography (OCTA)
OCTA maps retinal blood flow without dye. It helps assess the macular capillary network and can show if there is ischemia or other vascular changes, though it is less sensitive than dye tests for subtle leakage.
18) Fluorescein angiography (FA)
A fluorescent dye is injected into a vein in the arm. Pictures of the retina show a classic “petaloid” pattern of dye leakage in PCME and sometimes staining of the optic disc. FA confirms active leakage and can reveal coexisting vein occlusion or inflammation.
19) Fundus photography (color and autofluorescence when helpful)
Color photos document the macula for comparison. Autofluorescence can sometimes highlight patterns related to fluid or chronic changes. While not diagnostic alone, photos are a useful record across visits.
20) B-scan ultrasonography (when the view is cloudy)
If the cornea is hazy or there is significant media opacity, ultrasound helps rule out other problems (like a hidden retinal detachment) and supports safe planning for care until the view clears and OCT can be done.
Non-pharmacological treatments (therapies & “other” supports)
These steps do not replace medical therapy when it’s needed. They reduce triggers, protect healing tissues, or help you function better while the macula recovers.
Watchful waiting (in mild, early cases).
Description: Careful observation with follow-up exams and OCT scans while symptoms are mild.
Purpose: Avoid over-treatment when the eye may settle naturally.
Mechanism: Many PCME cases resolve as inflammation cools and the retinal barriers reseal.Tight blood sugar control (if you have diabetes).
Description: Work with your doctor on glucose/A1c.
Purpose: Diabetes increases macular edema risk and slows healing.
Mechanism: Stable glucose reduces inflammatory and vascular leak signals in retinal vessels.Optimize blood pressure and lipids.
Description: Follow your PCP’s plan for BP and cholesterol.
Purpose: Healthy vessels leak less.
Mechanism: Vascular stability supports the blood-retina barrier.Pause or adjust prostaglandin-analog glaucoma drops (if advised by your ophthalmologist).
Description: Temporarily switch to alternative glaucoma therapy during active PCME.
Purpose: Some prostaglandin drops can worsen barrier leak in susceptible pseudophakic eyes.
Mechanism: Reduces prostaglandin-mediated inflammation. EyeWikiTreat blepharitis and ocular surface inflammation.
Description: Lid hygiene, warm compresses, in-office care as advised.
Purpose: A calmer ocular surface reduces inflammatory signaling into the anterior segment.
Mechanism: Fewer inflammatory mediators bathing the front of the eye.Avoid eye rubbing and direct pressure.
Description: Use shields while sleeping in early weeks if recommended.
Purpose: Protects surgical wounds and reduces mechanical irritation.
Mechanism: Less micro-trauma and inflammation.Manage allergies.
Description: Reduce triggers; use non-ocular systemic allergy strategies your doctor approves.
Purpose: Itchy eyes → rubbing → irritation.
Mechanism: Decreases histamine-driven ocular surface inflammation.Quit smoking and avoid second-hand smoke.
Description: Smoking cessation programs, counseling.
Purpose: Smoking worsens vascular health and inflammation.
Mechanism: Improves tissue oxygenation and reduces oxidative stress.Wear UV-blocking sunglasses outdoors.
Description: Wraparound, high-quality UV filters.
Purpose: Comfort and reduced light-induced irritation.
Mechanism: Minimizes photic stress to healing tissues.Use large print, high-contrast settings, and brighter task lighting.
Description: Adjust devices and reading materials.
Purpose: Maintain function while vision is blurry.
Mechanism: Better signal-to-noise makes reading easier during recovery.Amsler grid or simple home vision checks.
Description: Daily quick check of straight lines and central blur.
Purpose: Early detection of worsening edema.
Mechanism: Prompts timely clinic review.Pace near work (20-20-20 rule).
Description: Every 20 minutes, look 20 feet away for 20 seconds.
Purpose: Eye comfort and dryness relief during healing.
Mechanism: Reduces strain and surface irritation.Treat sleep apnea (if present).
Description: Use CPAP consistently.
Purpose: Systemic hypoxia and vascular stress are bad for retinal health.
Mechanism: Improves oxygenation and vascular tone.Gentle aerobic exercise (as cleared by your doctor).
Description: Walking or similar movement.
Purpose: Cardiometabolic health supports healing.
Mechanism: Better endothelial function and anti-inflammatory effects.Healthy weight and nutrition pattern (see diet section).
Description: Emphasize anti-inflammatory foods.
Purpose: Support recovery environment.
Mechanism: Lowers systemic inflammatory load and oxidative stress.Defer Nd:YAG capsulotomy until PCME settles (unless your surgeon advises otherwise).
Description: Delay laser for cloudy posterior capsule while edema is active.
Purpose: Avoid extra inflammation while the macula is swollen.
Mechanism: Limits procedure-related inflammatory spikes.Early retina referral in high-risk eyes.
Description: If you have diabetes, uveitis, or surgical complications, see a retina specialist sooner.
Purpose: Faster escalation if needed.
Mechanism: Timely OCT-guided care improves outcomes.Control systemic inflammatory conditions.
Description: Work with rheumatology/PCP on autoimmune disorders.
Purpose: Systemic flares can feed ocular inflammation.
Mechanism: Lower circulating cytokines → less macular leak.Protective eye hygiene in the early postoperative period.
Description: Follow drop schedules, hand hygiene, and shield use as instructed.
Purpose: Prevent infection or irritation that could worsen inflammation.
Mechanism: Reduces new inflammatory triggers.Low-vision rehabilitation if vision is slow to recover.
Description: Occupational/low-vision therapy.
Purpose: Keep you safe and independent.
Mechanism: Tools and training maximize remaining vision while the macula heals.
Drug treatments
Doses below are typical clinical ranges; your doctor will tailor them to your eye, your risks, and your response.
Topical NSAIDs (ketorolac 0.5% QID; nepafenac 0.1% TID or 0.3% daily; bromfenac 0.07% daily).
Class: Non-steroidal anti-inflammatory drops.
Time: Often 4–12 weeks, sometimes longer if chronic.
Purpose: First-line for post-cataract inflammation and PCME.
Mechanism: Blocks cyclo-oxygenase → less prostaglandin-driven vascular leak.
Side effects: Stinging, rare corneal issues (very uncommon), dryness.
Evidence: NSAIDs reduce the risk and burden of PCME, and are effective in many cases—alone or with steroid drops. Cochrane LibraryCochranePubMedTopical corticosteroids (prednisolone acetate 1% QID→taper; difluprednate 0.05% QID→taper).
Class: Corticosteroids.
Time: Weeks to months with careful taper.
Purpose: Quiet stronger inflammation or steroid-responsive cases.
Mechanism: Broad anti-inflammatory gene modulation.
Side effects: Eye-pressure rise (watch IOP), delayed healing, infection risk.Carbonic anhydrase inhibitors — topical (dorzolamide 2% TID) or oral (acetazolamide 250 mg BID–TID).
Class: CAIs.
Time: Short trial of weeks; sometimes used as an add-on.
Purpose: Help dry the retina in inflammatory macular edema.
Mechanism: Alters fluid transport across the RPE to clear intraretinal fluid.
Side effects: Dorzolamide can sting; acetazolamide can cause tingling, fatigue, kidney stones, or rare choroidal effusions—only use under supervision. PMCScienceDirectMDPIPeriocular (sub-Tenon) triamcinolone (typical: 40 mg single injection).
Class: Corticosteroid injection around the eye.
Time: Single shot; effect lasts weeks to months.
Purpose: For cases not settling with drops.
Mechanism: Depot steroid diffuses into the macula to reduce leak.
Side effects: IOP rise, ptosis, rare globe perforation/infection.Intravitreal triamcinolone (4 mg/0.1 mL).
Class: Corticosteroid injection into the vitreous.
Time: Single injection; may be repeated if needed.
Purpose: Rescue for refractory PCME.
Mechanism: High intraocular steroid level suppresses inflammatory leak.
Side effects: IOP rise, floaters, cataract (not an issue in pseudophakia), endophthalmitis (very rare). EyeWikiDexamethasone intravitreal implant (0.7 mg).
Class: Sustained-release corticosteroid implant.
Time: Lasts ~3–4 months; may repeat based on response.
Purpose: Chronic or recurrent PCME, including in diabetics.
Mechanism: Long-acting steroid reduces macular inflammation and fluid.
Side effects: IOP rise, rare infection; needs sterile injection in clinic.
Evidence: Small studies and case series show improved thickness and vision in PCME. PMCPubMedAnti-VEGF injections (bevacizumab 1.25 mg/0.05 mL; ranibizumab 0.5 mg/0.05 mL).
Class: Vascular endothelial growth factor inhibitors.
Time: Given as needed; some eyes require a series.
Purpose: Selected refractory cases, especially when vascular leak is prominent.
Mechanism: Stabilizes leaky capillaries and reduces edema.
Side effects: Very rare infection, transient IOP spike.
Evidence: Case series show benefit in PCME that did not respond to other therapy. ScienceDirectEyeWikiCombination therapy (topical NSAID + topical steroid).
Class: Dual anti-inflammatory.
Time: Weeks to months with taper.
Purpose: Synergy for faster anatomic recovery.
Mechanism: Blocks prostaglandins and broader inflammatory pathways.
Side effects: As above for each class. EyeWikiSwitching off prostaglandin-analog glaucoma drops (temporarily), replacing with alternatives.
Class: Medication management step, not a new drug.
Time: During active PCME.
Purpose: Reduce risk of ongoing barrier leak.
Mechanism: Removes a prostaglandin-driven trigger. EyeWikiInterferon-α2b (topical, compounded 1 MIU/mL, QID) — off-label.
Class: Immunomodulator.
Time: Weeks to months in selected refractory cases.
Purpose: Rescue option when standard therapy fails and the specialist judges it appropriate.
Mechanism: Anti-inflammatory cytokine effects that may reduce macular leak.
Side effects: Surface irritation, cost/compounding; used only under retina specialist care.
Evidence: Small reports/series suggest potential benefit in refractory PCME. PMCLippincott Journals
Dietary “molecular” supplements
No supplement cures PCME. A few may support retinal health or inflammation control. Always ask your ophthalmologist first—some supplements interact with blood thinners or other medicines.
Omega-3s (EPA/DHA 1–2 g/day). Support anti-inflammatory lipid mediators; may help overall retinal vascular health.
Lutein (10 mg/day) + Zeaxanthin (2 mg/day). Macular carotenoids concentrate in the retina and act as antioxidants and blue-light filters.
Vitamin C (500–1000 mg/day). Antioxidant support; avoid very high doses if you have kidney stones.
Vitamin E (up to 200–400 IU/day). Lipid-phase antioxidant; be cautious with anticoagulants.
Zinc (up to 40–80 mg elemental/day short term). Cofactor in antioxidant enzymes; long-term high dosing can cause copper deficiency—use judiciously.
Alpha-lipoic acid (300–600 mg/day). Redox cycling antioxidant; sometimes used in diabetic neuropathy; may reduce oxidative stress.
N-acetylcysteine (600–1200 mg/day). Glutathione precursor with anti-oxidant/anti-inflammatory effects.
Coenzyme Q10 (100–200 mg/day). Mitochondrial antioxidant; general retinal metabolic support.
Curcumin (with piperine or phytosomal formulations, 500–1000 mg/day). Broad anti-inflammatory properties; watch for GI upset and interactions.
Saffron (20–30 mg/day). Antioxidant carotenoids (crocin/crocetin); some small retinal studies suggest functional benefits in other macular conditions; evidence in PCME is limited.
Again, these are optional adjuncts, not a replacement for medical treatment.
Advanced/biologic or regenerative-leaning” therapies
There are no approved stem-cell therapies or “immunity boosters” for PCME. Unregulated stem-cell eye injections have caused blindness; avoid any clinic offering them outside a regulated clinical trial. What retina specialists actually use are clinician-administered immunomodulators that help the macula dry. These overlap with the drug section above and are listed here to clarify expectations:
Dexamethasone intravitreal implant (0.7 mg). Long-acting steroid that suppresses inflammatory pathways and reduces edema; used for persistent PCME under sterile injection. PMCPubMed
Fluocinolone acetonide intravitreal implant (0.19 mg). Very long-acting steroid approved for uveitis/diabetic edema; occasionally considered off-label in chronic, stubborn PCME by subspecialists. (Discuss risks/benefits carefully.)
Intravitreal triamcinolone (4 mg/0.1 mL). Potent anti-inflammatory injection for refractory cases. EyeWiki
Anti-VEGF biologics (bevacizumab 1.25 mg, ranibizumab 0.5 mg). Biologic proteins that stabilize leaky retinal capillaries in selected PCME cases. ScienceDirect
Suprachoroidal triamcinolone (clinical product for uveitic edema). Delivers steroid to the back of the eye; role in PCME is evolving and off-label—specialist judgment required.
Topical interferon-α2b (1 MIU/mL QID, compounded), off-label. Immunomodulatory drop used by some centers in refractory inflammatory macular edema when standard options fail. PMC
Surgeries
Pars plana vitrectomy (PPV) for vitreomacular traction.
Procedure: The vitreous gel is removed; the surgeon releases traction on the macula.
Why: When mechanical pulling contributes to persistent edema, removing traction helps the macula dry and recover. EyeWikiPPV with epiretinal membrane (ERM) and internal limiting membrane (ILM) peel.
Procedure: During vitrectomy, thin scar tissue on the macula is peeled.
Why: ERM can distort the macula and sustain swelling; peeling flattens the retina and improves fluid movement. EyeWikiRemoval of retained lens fragments.
Procedure: Vitrectomy to remove lens pieces left after cataract surgery.
Why: Retained fragments can keep inflammation high and prolong PCME; removing them reduces the inflammatory drive. EyeWikiIOL reposition or exchange (for malposition or UGH syndrome).
Procedure: Move, fixate, or replace a problem intraocular lens.
Why: An unstable or chafing IOL can cause ongoing inflammation → persistent edema; fixing the lens removes the trigger. EyeWikiNd:YAG anterior vitreolysis in special cases of vitreous incarceration at the wound.
Procedure: Laser frees prolapsed vitreous strands from the incision.
Why: Trapped vitreous can tug the retina and maintain edema; releasing it may improve vision. (This is for carefully selected cases by experienced surgeons.) PubMed
Ways to prevent PCME
Combine topical NSAID + steroid around cataract surgery if you’re higher risk (for example, diabetes, uveitis, prior PCME), as your surgeon advises. Evidence supports NSAIDs for reducing PCME risk. Cochrane LibraryCochrane
Control blood sugar well before and after surgery.
Stabilize blood pressure and lipids.
Treat ocular surface disease and blepharitis before surgery.
Plan surgery to minimize iris trauma and vitreous traction; address posterior capsule rupture promptly (your surgeon’s domain).
If you use prostaglandin glaucoma drops, ask your surgeon about peri-operative adjustments. EyeWiki
Delay Nd:YAG capsulotomy for posterior capsule opacity until inflammation has settled.
Attend all post-op visits and follow drop schedules exactly.
Avoid eye rubbing and protect the eye while sleeping in the early weeks.
Get early retina input if you’re high-risk.
When to see a doctor urgently
Your vision suddenly worsens after an initial post-op improvement.
You notice new central blur, wavy lines (metamorphopsia), or a dark/gray spot.
You develop eye pain, redness, or light sensitivity (these can signal infection or severe inflammation and are emergencies).
You see bursts of floaters or flashes (could be a retinal tear—get checked promptly).
Your home monitoring shows rapid change.
What to eat and what to avoid
Eat fish (salmon, sardines) 2–3×/week for omega-3s; avoid very salty ultra-processed foods that worsen overall vascular health.
Eat leafy greens (spinach, kale) and colorful produce rich in carotenoids; avoid ultra-processed snacks high in refined oils and sugars.
Eat nuts/legumes for minerals and healthy fats; avoid smoking and second-hand smoke.
Drink adequate water; avoid excessive alcohol (it inflames and dehydrates).
Choose whole grains; avoid frequent high-glycemic desserts if you have diabetes.
Use olive oil and spices like turmeric/ginger in cooking; avoid constant deep-fried foods.
Maintain a steady weight with balanced portions; avoid crash diets that disturb glucose control.
Consider evidence-based supplements only with your doctor; avoid internet “eye cure” pills.
Eat foods with vitamin C (citrus, berries) and zinc (beans, seeds) reasonably; avoid megadoses without medical advice.
Keep caffeine moderate; avoid anything your doctor says conflicts with your medicines.
Frequently asked questions
1) Is PCME the same as diabetic macular edema?
No. Both are macular swelling, but PCME follows cataract surgery and is driven by surgery-related inflammation; diabetic macular edema is a chronic diabetes-related leak. The two can overlap if you have diabetes. EyeWiki
2) How long does PCME last?
Many cases improve over weeks to a few months; some take longer or become chronic. Cases linked to traction or ongoing inflammation often need injections or surgery. EyeWiki
3) Will I lose vision permanently?
Most people recover good vision, especially when treatment starts early. A minority have lasting blur, particularly if edema is severe or longstanding. PMC
4) Do I always need injections?
No. Many cases respond to drops (NSAID ± steroid). Injections or implants are for refractory edema. PubMed
5) Are NSAIDs or steroids better?
For prevention, evidence supports NSAIDs. For treatment, doctors often combine an NSAID with a steroid, then escalate if needed. Cochrane LibraryCochrane
6) What is OCT and why is it used?
OCT is a painless scan that shows macular thickness and tiny cysts. It guides when to start, change, or stop treatment.
7) What about fluorescein angiography (FA)?
FA can show the classic “petaloid” leak pattern in PCME, helpful in unclear cases. Your doctor chooses tests case by case. EyeWiki
8) Can my glaucoma drops cause or worsen PCME?
Some prostaglandin analogs can aggravate macular leak in susceptible pseudophakic eyes; your doctor may adjust them during active PCME. EyeWiki
9) Is acetazolamide safe for me?
It can help some inflammatory macular edema, but it has side effects (tingling, fatigue, kidney stones) and rare complications; it must be doctor-supervised. PMCMDPI
10) Are anti-VEGF shots only for diabetes/AMD?
They’re primarily for those diseases, but they’re also used in selected PCME that doesn’t respond to standard therapy. ScienceDirect
11) Are steroid implants safe?
They can be very effective but may raise eye pressure and require monitoring. Infections are very rare with proper sterile technique. PMC
12) Will a YAG laser fix my PCME?
Not usually. YAG is for a cloudy posterior capsule. In special cases with vitreous trapped in the wound, a targeted YAG vitreolysis may help—but this is uncommon and specialist-driven. PubMed
13) Can I fly, read, or use screens?
Yes, those don’t worsen macular edema. Use larger fonts and take breaks for comfort.
14) Is PCME contagious or related to hygiene?
No. It’s inflammation-related, not infectious (unless you have another rare post-op problem—your doctor will rule that out).
15) How do we decide when to stop treatment?
Your team watches vision and OCT thickness. If the retina is dry and vision is stable, drops are tapered; if fluid returns, treatment can restart or be escalated.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 23, 2025.
